These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26572097)

  • 21. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota.
    Cebula A; Seweryn M; Rempala GA; Pabla SS; McIndoe RA; Denning TL; Bry L; Kraj P; Kisielow P; Ignatowicz L
    Nature; 2013 May; 497(7448):258-62. PubMed ID: 23624374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease.
    Milner JD; Ward JM; Keane-Myers A; Paul WE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):576-81. PubMed ID: 17202252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Default" generation of neonatal regulatory T cells.
    Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W
    J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice.
    Hichami A; Yessoufou A; Ghiringhelli F; Salvadori F; Moutairou K; Zwetyenga N; Khan NA
    Biochimie; 2016 Dec; 131():1-10. PubMed ID: 27613402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanisms shaping the repertoire of CD4
    Kraj P; Ignatowicz L
    Immunology; 2018 Mar; 153(3):290-296. PubMed ID: 29106696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
    Chiu BC; Stolberg VR; Zhang H; Chensue SW
    Mech Ageing Dev; 2007; 128(11-12):618-27. PubMed ID: 17961632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice.
    Hori S; Haury M; Lafaille JJ; Demengeot J; Coutinho A
    Eur J Immunol; 2002 Dec; 32(12):3729-35. PubMed ID: 12516567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells.
    Kogina K; Shoda H; Yamaguchi Y; Tsuno NH; Takahashi K; Fujio K; Yamamoto K
    Mol Cells; 2009 Aug; 28(2):125-30. PubMed ID: 19714314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function.
    Su Y; Huang X; Wang S; Min WP; Yin Z; Jevnikar AM; Zhang ZX
    Eur J Immunol; 2012 May; 42(5):1216-25. PubMed ID: 22539294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice.
    Lee H; Nho D; Chung HS; Lee H; Shin MK; Kim SH; Bae H
    Kidney Int; 2010 Dec; 78(11):1100-9. PubMed ID: 20463654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy.
    Alderson KL; Zhou Q; Berner V; Wilkins DE; Weiss JM; Blazar BR; Welniak LA; Wiltrout RH; Redelman D; Murphy WJ
    J Immunol; 2008 Mar; 180(5):2981-8. PubMed ID: 18292520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foxp3+ regulatory T-cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen.
    Milanez-Almeida P; Meyer-Hermann M; Toker A; Khailaie S; Huehn J
    Eur J Immunol; 2015 Jan; 45(1):153-66. PubMed ID: 25330759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
    Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
    Mor A; Keren G; Kloog Y; George J
    Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
    Chen X; Oppenheim JJ; Howard OM
    J Leukoc Biol; 2005 Jul; 78(1):114-21. PubMed ID: 15845645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KLRG1 impairs regulatory T-cell competitive fitness in the gut.
    Meinicke H; Bremser A; Brack M; Schrenk K; Pircher H; Izcue A
    Immunology; 2017 Sep; 152(1):65-73. PubMed ID: 28437578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.